A Texas federal judge suspended the FDA's approval of the abortion drug mifepristone, leading to concerns about access to the drug for women across the country. Known for being the first drug used in the two-drug protocol for abortions, mifepristone is considered safe and effective by the FDA. The ruling has been met with criticism as it is considered atypical for a single judge to override a decades-old decision made by an expert agency. The plaintiffs in the case, a coalition of anti-abortion organizations and physicians, do not have the right to be in court asking for this remedy as they lack standing, which is a core requirement of any lawsuit in federal court. Despite the suspension being lifted for seven days, this could render mifepristone unavailable nationally in the future. While the federal government has already filed a notice of appeal in the Fifth Circuit and is seeking emergency relief, legal experts are calling for the Biden administration to act forcefully to highlight the lawlessness of the ruling to limit any potential damage. The ruling by Judge Matthew Kacsmaryk is considered a travesty for women's healthcare, principles of democracy, notions of judicial impartiality and the rule of law.